EPAM Systems announced today its acquisition of Odysseus Data Services, a top health data analytics company. This acquisition of Odysseus will expand EPAM’s ability to transform the life sciences value chain through advanced data analytics, data methods, and artificial intelligence (AI).
Odysseus, headquartered in Cambridge, Massachusetts, generates healthcare data insights and evidence for clients through skilled data science and analytics, software engineering and data management and ontology and vocabulary management.
Odysseus is an active member of the Observational Health Data Sciences and Informatics” (OHDSI) collaborative and is intimately involved in the open standards and open science community through participation in research and development, including OMOP CDM, open source tools and methods.
“We are pleased to have Odysseus join EPAM. With their strong capabilities in Real-World Evidence and Real-World Data — the ‘glue’ between multiple segments of the life sciences value chain — our natural synergies make this an exciting time to add this to our portfolio to help our clients achieve better outcomes,” said Greg Killian, Senior Vice President of Life Sciences at EPAM. “We see the next wave of innovation based on standardized data powering AI and GenAI to improve life sciences research, clinical studies and post-market surveillance. Based on the combined strengths of EPAM and Odysseus, we are well positioned to lead that innovation.”
“We’re excited to join the EPAM family,” said Gregory Klebanov, CEO of Odysseus. “With EPAM’s strong foundation in AI, machine learning, data analytics and data management and cloud infrastructure combined with our healthcare data analytics and Real World Evidence expertise, we can address the whole life sciences value chain more comprehensively.”
Also Read: 76% of Indian employees say their team is pulled in too many directions: Atlassian
